Loading clinical trials...
Loading clinical trials...
Phase II Study of the Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma
Conditions
Interventions
Rituximab -CHOP plus Velcade
Locations
4
France
Hôpital Saint-Louis
Paris, Paris 10, France
Institut Gustave Roussy
Villejuif, Villejuif Cedex, France
Hôpital Henri Mondor
Créteil, France
Hôpital Lyon Sud
Pierre-Bénite, France
Start Date
January 1, 2005
Primary Completion Date
January 1, 2006
Completion Date
January 1, 2006
Last Updated
August 23, 2018
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Lymphoma Study Association
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions